Skip to main content
. 2012 Aug;50(8):2793–2795. doi: 10.1128/JCM.00678-12

Table 1.

MLVA type distribution of 152 M. pneumoniae clinical isolates

MLVA typea No. of isolates:
Distribution by yr (no. of resistant strains)
Macrolide susceptibleb Macrolide resistantc 2005 2006 2007 2008 2009
1 2 0 0 0 0 0 0
2 0 14 0 0 0 3 11
3 3 17 0 2 6 0 9
4 1 3 3 0 0 0 0
5 0 13 0 1 1 8 3
6 0 4 0 0 1 1 2
7 4 1 0 0 0 0 1
8 1 17 0 3 3 2 9
9 1 13 0 2 3 5 3
10 1 0 0 0 0 0 0
11 1 20 0 3 5 8 4
12 1 11 0 1 2 5 3
13 0 10 0 0 2 4 4
14 0 1 0 0 0 1 0
15 0 5 0 1 1 2 1
16 0 2 0 0 0 1 1
17 0 6 0 0 0 3 3
Total 15 137 3 13 24 43 54
a

The MLVA types of two reference strains were not included in this table. M. pneumoniae reference strain M129 belonged to MLVA type 13, and M. pneumoniae reference strain FH alone showed a separate MLVA type.

b

Susceptible, erythromycin MIC of ≤0.5μg/ml.

c

Resistant, erythromycin MIC of ≥1μg/ml. All erythromycin-resistant strains had a MIC of ≥64μg/ml in the present study.